Iman Osman, MD

Professor, Ronald O. Perelman Department of Dermatology

Professor, Department of Medicine

Professor, Department of Urology

Iman Osman

Keywords
melanoma
Read more
Read more

Phone

212-263-9076

Fax

212-263-5819

Academic office

522 First Avenue

Smilow, 4th Floor, Suite 405

New York, NY 10016

Lab Website
Osman Lab
Is this your profile?
Edit profile

These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...

Positions

Professor, Ronald O. Perelman Department of Dermatology

Professor, Department of Medicine

Professor, Department of Urology

Associate Dean for Translational Research Support

Director, Interdisciplinary Melanoma Cooperative Group

Graduate Education

MD from National Cancer Institute

MD from Cairo University

Residency And Fellowship Training

Fellowship, Memorial Sloan-Kettering Cancer Center

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Gowen, Michael F; Giles, Keith M; Simpson, Danny; Tchack, Jeremy; Zhou, Hua; Moran, Una; Dawood, Zarmeena; Pavlick, Anna C; Hu, Shaohui; Wilson, Melissa A; Zhong, Hua; Krogsgaard, Michelle; Kirchhoff, Tomas; Osman, Iman

Journal of translational medicine. 2018 Apr 02; 16(1):82-82

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche

Plebanek, Michael P; Angeloni, Nicholas L; Vinokour, Elena; Li, Jia; Henkin, Anna; Martinez-Marin, Dalia; Filleur, Stephanie; Bhowmick, Reshma; Henkin, Jack; Miller, Stephen D; Ifergan, Igal; Lee, Yesung; Osman, Iman; Thaxton, C Shad; Volpert, Olga V

Nature communications. 2017 Nov 06; 8(1):1319-1319

Germline determinants of immune related adverse events (irAEs) in melanoma immunotherapy response [Meeting Abstract]

Kirchhoff, T; Ferguson, R; Simpson, D; Kazlow, E; Martinez, C; Vogelsang, M; Wilson, M; Pavlick, AC; Weber, JS; Osman, I

Annals of oncology. 2017 SEP; 28:?-?

Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature

Utter, Kierstin; Goldman, Chloe; Weiss, Sarah A; Shapiro, Richard L; Berman, Russell S; Wilson, Melissa Ann; Pavlick, Anna C; Osman, Iman

Oncology (New York). 2017 Jul 27; 93(4):249-258

Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients

Rosenbaum, Brooke E; Schafer, Christine N; Han, Sung Won; Osman, Iman; Zhong, Hua; Brinster, Nooshin

Modern pathology. 2017 Jul 21; 30(10):1402-1410

PRC2-mediated silencing of circRNA CDR1as drives miR-7- independent melanoma metastasis [Meeting Abstract]

Hanniford, D; Moubarak, R; Imig, J; Ulloa, A; Sendra, B S; Karz, A; Osman, I; Aifantis, I; Hernando, E

Cancer research. 2017 July; (American):

Targeting EZH2 in acral lentiginous melanoma (ALM) [Meeting Abstract]

Izsak, A; Giles, K M; Lui, K P; Weiss, S A; Moran, U; De, Miera E V -S; Stein, J; Lee, A Y; Darvishian, F; Shapiro, R L; Berman, R S; Pavlick, A C; Wilson, M; Osman, I

Journal of clinical oncology. 2017 Jun 20; (2017):

Mutation burden as a potential prognostic marker of melanoma progression and survival [Meeting Abstract]

Simpson, D; Ferguson, R; Martinez, C N; Kazlow, E; Moran, U; Heguy, A; Hanniford, D; Hernando, E; Osman, I; Kirchhoff, T

Journal of clinical oncology. 2017 Jun 20; (2017):

See All Publications (257)